Carfilzomib

Overview

Carfilzomib (PR-171) is a second-generation, irreversible proteasome inhibitor targeting the β5 subunit (IC50 = 5.2 nM) and β5i subunit (IC50 = 14 nM), inducing apoptosis in multiple myeloma and other cancers. Reagent-grade; for laboratory research purposes only.

Application

Products > ADC Linker, ADC Payload > ADC Payload | Products > ADC Linker, ADC Payload > ADC Payload > Carfilzomib

Product Information

• Catalog No.: BP-43632
• CAS No.: 868540-17-4
• Molecular Formula: C40H57N5O7
• Molecular Weight: 719.9
• Storage: -20°C
• Availability: 24 Hours

Source

Original product source